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Summary: A rate-limiting step in breast cancer progression is acquisition of the invasive phenotype, which can precede 
metastasis. Expression of cell-surface proteases at the leading edge of a migrating cell provides cells with a mechanism to 
cross tissue barriers. A newly appreciated mechanism that may be relevant for breast cancer cell invasion is the formation 
of invadopodia, well-deﬁ  ned structures that project from the ventral membrane and promote degradation of the extracel-
lular matrix, allowing the cell to cross a tissue barrier. Recently, there has been some controversy and discussion as to 
whether invadopodia, which are associated with carcinoma cells, are related to a similar structure called podosomes, which 
are associated with normal cells. Invadopodia and podosomes share many common characteristics, including a similar size, 
shape, subcellular localization and an ability to promote invasion. These two structures also share many common protein 
components, which we outline herein. It has been speculated that podosomes may be precursors to invadopodia and by 
extension both structures may be relevant to cancer cell invasion. Here, we compare and contrast the protein components 
of invadopodia and podosomes and discuss a potential role for these proteins and the evidence that supports a role for 
invadopodia and podosomes in breast cancer invasion.
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Introduction
Breast cancer is a complex disease that is estimated to affect 182,460 women in 2008 with 40,480 
predicted mortalities in the United States, alone. The most commonly diagnosed form of breast cancer 
is invasive ductal carcinoma, which is usually detected as a stage I disease. When treated with standard 
therapy (lumpectomy, radiation and tamoxifen) invasive ductal carcinoma has a ﬁ  ve-year survival rate 
of approximately 80%. Initially, invasive ductal carcinoma begins as an atypical hyperplasia, typiﬁ  ed 
by a loss of balance between growth and apoptosis of the epithelial cells that line the breast ducts. Here, 
the cells appear to ﬁ  ll the duct and show a characteristic pattern of increased mitotic activity throughout 
the hyperplasia. The disease can then progress to ductal carcinoma in situ where it remains contained 
within the ducts; however, mitotic activity is elevated throughout the tumor. Subsequently, these cells 
can become invasive. They can move as either a collective “sheet” of cells or they can separate away 
from the ductal carcinoma in situ and move independently. These newly invasive cells can breach the 
barrier of the ducts and move into the collagen matrix of the breast where they can establish a tumor. 
Invasion requires increased migratory capacity and protease expression. Ultimately, these cells may 
gain entry into the lymph nodes where they can metastasize, or they may intravasate directly into blood 
vessels, where they can be transported and trapped within the capillaries. Here, the cells can extravasate 
into surrounding tissue and potentially establish a distant site metastasis. Thus, a key feature in the 
progression of breast cancer is acquisition of the invasive phenotype. Clearly, if breast cancer invasion 
could be blocked, tumor growth would be conﬁ  ned and the disease rendered manageable.
Invasion occurs by different mechanisms. Migrating cells may express and secrete proteases at the 
leading edge of the carcinoma cell. These proteases degrade the extracellular matrix (ECM) and create 
a path of least resistance through which cells migrate and cross tissue barriers (Gimona et al. 2008). 
Alternatively, carcinoma cells can ‘push’ their way through a loose matrix, moving in a fashion that 
might be analogous to amoeboid motility, which can occur independent of protease activity (Sahai and 18
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Marshall, 2003). Invasive cells can also move 
ventrally, using podosomes or invadopodia, both 
of which promote the local release of protease 
activity and allow the cell to degrade the extracel-
lular matrix and cross a tissue barrier.
Invadopodia and Podosomes
Invadopodia share many characteristics with podo-
somes, thus, there has been some controversy as 
to whether podosomes and invadopodia are related 
or distinct structures. Several very ﬁ  ne reviews 
have been written recently on this subject (Ayala 
et al. 2006; Yamaguchi and Condeelis, 2007; 
Linder, 2007; Gimona et al. 2008), that outline 
podosome and invadopodium structure and func-
tion and discuss some of the aspects of them that 
are common and distinct. At the core of this con-
troversy is whether podosomes are precursors to 
invadopodia, and by extension, whether podo-
somes (like invadopodia) are relevant for cancer 
cell invasion. Alternatively, it has been speculated 
that podosomes and invadopodia could have both 
evolved from some common primordial structure. 
Here, we will review the protein components of 
podosomes and invadopodia and the data that 
indicate these structures may be related and rele-
vant for breast cancer invasion.
Structural Features
Both podosomes and invadopodia are functional 
structures that form on the ventral membrane of 
cells and modulate the release and activation of 
proteases that degrade the extracellular matrix and 
promote the ability of cells to cross tissue barriers. 
The main differences are the types of cells in which 
they have been identiﬁ  ed and their relative size. 
Podosomes are associated with normal cells, such 
as macrophages, osteoclasts, dendritic cells, epi-
thelial cells, smooth muscle cells and ﬁ  broblasts. 
They are relatively small, about 1.0 µm in diam-
eter and extend into the matrix 0.5 µm in length 
(Linder and Aepfelbacher, 2003). Podosomes can 
coalesce and form larger, ‘donut’ shaped structures 
that appear to be clusters of podosomes and are 
about 5 µm in diameter (Gringel et al. 2006; Gu 
et al. 2007). This difference in size could be related 
to changes in higher order structure or could cor-
relate in part with a difference in the organization 
of actin filaments within them (Gimona et al. 
2008). Interestingly, the size of the structure 
appears to correlate with half-life. Podosomes have 
a relatively short half-life, 2–10 minutes, however, 
larger podosomes appear to have a longer half-life 
(Gringel et al. 2006; Gu et al. 2007). In another 
level of higher organization, podosomes can clus-
ter and form a larger ring structure called a rosette, 
which is characteristic of oncogene-transformed 
ﬁ  broblasts (Linder and Aepfelbacher, 2003). In yet 
a third higher order structure, podosomes can 
cluster together like a tightly connected rosette and 
form a ‘sealing zone’, which is a characteristic 
structure associated with osteoclasts and their bone 
resorption function.
Invadopodia on the other hand are associated 
with carcinoma cells and have been described as 
larger structures, up to 8 µm in diameter and 
2–5 µm in length based on immunoﬂ  uorescence 
confocal microscopy analysis (Linder, 2007). 
Invadopodia can be detected, in part, by identifying 
F-actin in a structure of the appropriate size and 
shape, on the ventral membrane, using scanning 
confocal immunoﬂ  uorescence microscopy (0.7 µm 
scanning thickness) (Fig. 1A-C). Herein, one can 
turn the cells on their side and detect the F-actin 
protruding into the extracellular matrix, which 
becomes degraded (no ‘green’) (Fig. 1D-E).
Interestingly, an electron microscopy ultrastruc-
ture study demonstrated that invadopodia had a 
slender structure, 0.8 µm–1.0 µm in diameter and 
2 µm or more in length (Artym et al. 2006). How-
ever, another very thorough study by Buccione 
and colleagues using a combined electron micros-
copy and confocal light and immunoﬂ  uorescence 
microscopy approach that appeared to show inva-
dopodia can cluster together, which would make 
them appear as larger diameter structures by light 
microscopy (Baldassarre et al. 2003). This observa-
tion could be analogous to the difference between 
small and large podosomes (Gu et al. 2007). Inva-
dopodia have a longer half-life than podosomes, 
estimated anywhere from 1–3 hours (Artym et al. 
2006; Linder, 2007). However, invadopodia life 
span appears to correlate well with whether the 
carcinoma cell is migrating. Migrating cells showed 
shorter-lived invadopodia while static cells showed 
longer-lived invadopodia (Yamaguchi et al. 2005; 
Artym et al. 2006). It is not clear whether invado-
podia formed in migrating cells have a different 
diameter relative to those that would form in a static 
cell. Nevertheless, it may be possible that carcinoma 
cells need to become static or less migratory 
(i.e. confront a tissue barrier) in order to generate 
a long-lived invadopodia.19
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Figure 1. Invadopodia formation in Src527F-expressing MDA-MB-231 breast carcinoma cells. (A) TRITC-phalloidin labeling of F-actin 
demonstrates actin-rich punctate structures around the cell peripheray (arrows) as detected by confocal immunoﬂ  uorescence microscopy 
on the ventral membrane (0.7 µm scanning thickness). (B) The cells were plated on Alexa488-gelatin/ﬁ  bronectin and allowed to degrade 
the extracellular matrix, as seen by zones of clearing in the ‘green’ extracellular matrix (arrows). (C) Merged image shows the overlap of 
F-actin with proteolytic activity. (D) Larger panel shows zones of clearing or active proteolysis. The rectangular images below and beneath 
illustrate a cross section of degraded extracellular matrix showing ‘red’ F-actin protruding into the ‘green’ extracellular matrix by both x-z and 
y-z images (note where the red lines intersect, cells are turned on the side and ‘red’ actin is detected in the zones of clearing which now lack 
‘green’ extracellular matrix. (E) Close-up view of (D) where red arrow in x-z and y-z show ‘red’ F-actin protruding into the ‘green’ extracel-
lular matrix as an invadopodia. Similarly, the rectangular images show ‘red’ actin present in zones of clearing where the ‘green’ extracellular 
matrix has been degraded. Cells were the kind gift of Susette Mueller (Bowden et al. 2006).
Protein Biomarkers for Podosomes 
and Invadopodia
Recently, a meeting on podosomes and invado-
podia was held at Cold Spring Harbor where the 
relationship of podosomes and invadopodia were 
discussed (“Podosomes and Invadopodia: Signa-
tures of the wandering cell?”, November 26–29, 
2007, John Condeelis, Ph.D., Chair). Although it 
was not resolved whether these are related or 
distinct structures, it was generally agreed that 
there should be a set of criteria used to deﬁ  ne an 
‘actin-rich dot’ on a ventral cell membrane as a 
podosome or an invadopodia. The consensus 
suggestion was that these structures should be 
imaged on the ventral membrane by confocal 
immunoﬂ  uorescence microscopy at a scanning 
thickness of 0.7–1.0 µm. These structures should 
express actin in the core, as well as a reliable 
marker protein that differentiates invadopodia and 
podosomes from focal adhesions, such as 
cortactin, Tks5 or dynamin (Linder, 2007). Lastly, 
the ‘biomarkers’ should be detected in association 
with functional proteolytic activity by seeding the 
cells on a FITC-gelatin/ﬁ  bronectin matrix and 
demonstrating that the biomarker for podosomes 
or invadopodia appear over zones of clearing 
where proteases have digested the matrix (Bowden 
et al. 2001). Using these criteria, a number of 
proteins have been described as associated with 
podosomes and invadopodia (Table 1). As 
TRITC-phalloidin Alexa 488-Gelatin Merged
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Table 1. Comparison of podosome and invadopodia associated proteins.
Podosomes Invadopodia Function
Cytoskeletal components
Actin (Tarone et al. 1985) Actin (Mueller et al. 1992) Regulates cell contractility, motility 
and shape
Microtubules (Babb et al. 1997) Unclear Promote movement of motor 
proteins and vesicle transport
Intermediate Filaments (Correia 
et al. 1999)
Unclear Cell shape and support
Actin ﬁ  lament contractility
Tropomyosin 4 (Burgstaller and 
Gimona, 2004)
Unknown Regulates actin ﬁ  lament contraction
Caldesmon (Eves et al. 2006) Caldesmon (Yoshio et al. 2007) Regulates actin ﬁ  lament contraction
Calmodulin (Eves et al. 2006) Calmodulin (Bourguignon et al. 
1998)
Ca
+2 and actin ﬁ  lament binding 
protein that can affect contraction
Myosin IIA ((Burgstaller and 
Gimona, 2004; Kopp et al. 2006)
Myosin II (implied in (Bourguignon 
et al. 1998)
Binds actin ﬁ  laments, provides 
contractile force
Calponin (Gimona et al. 2003) Unknown Ca
+2 binding protein and regulator of 
myosin II function
Actin ﬁ  lament cross linking
Sm22α (Transgelin) (Gimona et al. 
2003)
Unknown Regulates dynamic changes in actin 
ﬁ  lament cross linking and mesh-
working
AFAP-110 (Gatesman et al. 2004) AFAP-110 (Gatesman et al. 2004) Regulates dynamic changes in 
actin filament cross linking and 
meshworking, src activating 
protein
Fimbrin (Messier et al. 1993; Babb 
et al. 1997)
Unknown Actin ﬁ  lament cross linking protein
α-actinin (Chen, 1989) α-actinin (Mueller et al. 1992) Actin ﬁ  lament cross linking protein
Tensin (Hiura et al. 1995) Tensin (Mueller et al.1992) Actin ﬁ  lament cross linking protein
Palladin (Mykkanen et al. 2001) Unknown Actin ﬁ  lament cross linking, may link 
to VASP/mENA
Actin ﬁ  lament branching
VASP (Mykkanen et al.2001, 2001; 
Spinardi and Marchisio, 2006)
Unknown Actin ﬁ  lament barbed end binding 
protein, promote motility, reduce 
Arp2/3 formation
Arp2/3 (Mizutani et al. 2002) Arp2/3 (Yamaguchi et al. 2005) Actin ﬁ  lament polymerization and 
branching
WASp (Calle et al. 2006; Chellaiah, 
2006)
WASp (Desai et al. 2008) Modulates actin ﬁ  lament 
polymerization
N-Wasp (Mizutani et al. 2002) N-Wasp (Yamaguchi et al. 2005) Modulates actin ﬁ  lament 
polymerization
WIP (Anton et al. 2007; Chabadel 
et al. 2007)
Unknown Modulator of WASp and N-WASp 
function
HSP90 (Park et al. 2005) Unknown Chaperones N-WASP and regulates 
its ability to affect actin ﬁ  lament 
branching
(Continued)21
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Table 1. Continued.
Podosomes Invadopodia Function
CDC42 (Tatin et al. 2006; Moreau 
et al. 2006)
CDC42 (Furmaniak- Kazmierczak 
et al. 2007)
Affector of actin ﬁ  lament branching 
and polymerization via Arp2/3 and 
N-WASp, Small GTP binding 
protein, regulates ﬁ  lopodia formation
Cortactin (Webb et al. 2006) Cortactin (Bowden et al. 1999) Promotes actin ﬁ  lament 
polymerization and branching as an 
Arp2/3 modulator
Actin ﬁ  lament severing/capping
Gelsolin (Biswas et al. 2004) Unknown Regulates actin ﬁ  lament severing 
and capping
Coﬁ  lin (Linder and Aepfelbacher, 
2003)
Coﬁ  lin (Yamaguchi et al. 2005) Regulates actin ﬁ  lament 
depolymerization and severing
Unknown Nck (Yamaguchi et al. 2005) Adaptor protein and regulator of 
actin ﬁ  lament polymerization
Actin ﬁ  lament bridging
Talin (Marchisio et al. 1988) Talin (Mueller et al. 1992) Links integrins to actin ﬁ  laments
Vinculin (Chen, 1989) Vinculin (Mueller et al. 1992) Links integrins to actin ﬁ  laments
Zyxin (Spinardi and Marchisio, 
2006)
Unknown Actin scaffolding protein, biosensor 
that can modulate transcriptional 
changes in response to adhesion
Unknown Ankyrin (Bourguignon et al. 1998) Links actin ﬁ  laments with integral 
membrane proteins
Kindlins (Ussar et al. 2006) Unknown Links actin ﬁ  laments to membrane
Intermediate Filaments
Vimentin (Correia et al. 1999) Unknown Intermediate ﬁ  lament protein, 
regulates positioning of organelles
Microtubules
Kinesin-3 (Kopp et al. 2006) Unknown Motor protein, vesicle transport
Cell Adhesion
β1, α3β1, α5β1, α6β1, αVβ3 
Integrins (Marchisio et al. 1988; 
Spinardi and Marchisio, 2006; 
Calle et al. 2006)
β1, β3, αvβ3 Integrins (Deryugina 
et al. 2001) (Mueller et al. 1992; 
Nakahara et al. 1998)
Link cellular ventral membrane to 
the extracellular matrix
Unknown Endoglin (Oxmann et al. 2008) Transmembrane receptor part of 
TGFβ receptor complex and 
participates in cell adhesion
CD44 (Chabadel et al. 2007) CD44 (Bourguignon et al. 1998) Cell adhesion molecule that binds 
hyaluronic acid, MMP’s, collagen, 
osteopontin
Adaptor Proteins
Paxillin (Spinardi and Marchisio, 
2006;Calle et al. 2006)
Paxillin (Mueller et al. 1992) Fak binding partner. Transcriptional 
activator.
p130cas (Honda et al. 1998; Yogo 
et al. 2006)
Unknown Src binding partner. Required for 
transformation and podosome 
formation
(Continued)22
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Table 1. Continued.
Podosomes Invadopodia Function
Tks5/FISH (Abram et al. 2003) Tks5/FISH (Seals et al. 2005) 5 SH3 domains, podosome ring 
protein
Eps8 (Goicoechea et al. 2006) Unknown Adaptor protein, binds receptors
Grb2 (Spinardi and Marchisio, 
2006)
Unknown Links to cell growth and RTK binding
Cbl (Bruzzaniti et al. 2005) Cbl (Nam et al. 2007) Adaptor, linked to ubiquitin machinery
STAT5 (Poincloux et al. 2007) Unknown Modulate transcription in response 
to cytosolic signaling
Calcitonin (Shyu et al. 2007) Unknown 32 amino acid polypeptide that binds 
Ca
+2 and reduces local Ca
+2 levels
Caveolin 1 (Colonna and Podesta, 
2005)
Unknown Scaffolding protein, links integrins to 
tyrosine kinases, component of lipid 
rafts
Tyrosine kinases
Src (Tarone et al. 1985) Src (Chen, 1989) PTK
Pyk2 (Chiusaroli et al. 2004) Unknown PTK, Fak-like
Csk (Howell and Cooper, 1994) Unknown Regulator of Src
Fak (Seals et al. 2005) Fak (Hauck et al. 2002) Integrin associated. Controversial 
association with invadopodia or 
podosomes
Tyrosine Phosphatases
Unknown PTP1B (Cortesio et al. 2008) Regulator of cSrc
PTP epsilon (Chiusaroli et al. 2004) Unknown Regulator of cSrc
Ser/thr kinases
Pak4 (Gringel et al. 2006) Unknown Effector of actin ﬁ  lament cross 
linking
Unknown PKCmu (Bowden et al. 1999) Effector of actin ﬁ  lament cross 
linking
Erk/Mek (Redondo-Munoz et al. 
2006)
Erk/Mek (Furmaniak- Kazmierczak 
et al. 2007)
Effector of actin ﬁ  lament integrity
Effectors of small GTP binding 
proteins and related signaling
αPIX (Gringel et al. 2006) PIX (Furmaniak-Kazmierczak et al. 
2007)
Pak binding partner and guanine 
nucleotide exchange factor (GEF)
ASAP1 (Bharti et al. 2007) ASAP1 (Nam et al. 2007) Arf GAP that uses lipids to become 
active (bind PH domain)
p190RhoGap (Burgstaller and 
Gimona, 2004)
p190RhoGap (Nakahara et al. 
1998)
Negatively Regulates Rho function 
as a GAP
Unknown Rock II (Vishnubhotla et al. 2007) Positively Regulates Rho function
Dynamin2 (Ochoa et al. 2000) Dynamin 2 (McNiven et al. 2004) Affect vesicles and membrane 
invaginations that secrete MMPs, 
GTPase
Endophilin2 (Ochoa et al. 2000) Unknown Dynamin 2 and synaptojanin binding 
partner
(Continued)23
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Table 1. Continued.
Podosomes Invadopodia Function
Lipid signaling
SHIP-2 (Yogo et al. 2006) Unknown Phosphoinositide 5’ phosphatase 
with SH2 domain
Unknown Synaptojanin 2 (Chuang et al. 
2004)
Phosphoinositide 5’-phosphatase, 
vesicle uncoating, effector of Rac1
CIN85 (Gaidos et al. 2007) CIN85 (Nam et al. 2007) Component of endocytic
vesicles and binds Arf6 and ASAP1 
(Arf6 GAP), associates with Cbl 
E3- ligase
Proteases
MT1-MMP (Sato et al. 1997) MT1-MMP (Chen and Wang, 1999) Membrane bound metalloproteinase
ADAM12 (Abram et al. 2003) Unknown A type of MMP
MMP2 (Tatin et al. 2006) MMP2 (Deryugina et al. 2002) Soluble metalloproteinase, colla-
genase and gelatinase
MMP9 (Linder, 2007) MMP9 (Linder, 2007) Soluble metalloproteinase, colla-
genase and gelatinase
Calpain 2 (Calle et al. 2006) Calpain 2 (Cortesio et al. 2008) Ca
+2 dependent cysteine protease
Unknown Seprase (Ghersi et al. 2006) Gelatinase and serine protease
Unknown DPP4/CD26 (O’Brien and 
O’Connor, 2008)
Broad spectrum protease, degrades 
incretins
Unknown uPAR (Kindzelskii et al. 2004) Can link to integrins via UPARAP, 
binds uPA
Unknown uPA (urokinase) (Kindzelskii et al. 
2004)
Serine protease
Unknown Type II serine protease (O’Brien 
and O’Connor, 2008)
Serine protease
Unknown Invadolysin (likely) (McHugh et al. 
2004)
Metalloprotease, cleaves lamin
Unknown Legumain (Liu et al. 2003) Cysteine protease
Unknown means unknown.
podosomes are better studied than invadopodia, 
more protein components have been identiﬁ  ed in 
association with podosomes. Nevertheless, it is 
clear that they share at least 32 common protein 
components, and likely more. In only one case 
did we ﬁ  nd a controversy where one protein, 
tubulin, may be uniquely relevant for podosomes. 
Microtubular structures appear to be required for 
podosome dynamics but may be less important 
for invadopodia (Linder et al. 2000; Destaing 
et al. 2003; Destaing et al. 2005). In agreement 
with a role for microtubular structures supporting 
podosome dynamics, treatment of osteoclast cells 
with nocodazole did disrupt podosome location 
(Babb et al. 1997) and the microtubular-associated 
protein kinesin appears to be important for podo-
some dynamics (Kopp et al. 2006). Although 
there are data to indicate tubulin could be associ-
ated with invadopodia (Strohmaier et al. 2000), 
treatment of the Met-1 breast cancer cell line with 
colchicine did not inhibit invadopodia formation 
(Bourguignon et al. 1998). In this regard, it has 
been speculated that because podosomes are more 
dynamic structures than invadopodia, microtu-
bules may not be required for invadopodia forma-
tion and function (Linder, 2007). If true, then it 
would be interesting to determine if there is a 
differential requirement of microtubular structures 24
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for larger, long-lived podosomes relative to 
smaller, short-lived podosomes. This is an under-
studied area that warrants a closer look. Other-
wise, the protein components of podosomes and 
invadopodia listed in Table 1 tell a similar story. 
Actin ﬁ  laments form the core of theses structures 
and an array of actin ﬁ  lament contractility, cross 
linking, branching and severing/capping proteins 
are represented in each structure and regulate the 
dynamic changes in actin ﬁ  lament organization, 
and by extension, the shape and the half-life of 
these structures in response to cellular signals. 
There are also proteins in place that can link the 
cytoskeleton to integrins and/or the membrane, 
which would promote interactions with the extra-
cellular matrix. Adaptor proteins are present, 
which could serve to bridge interactions between 
signaling proteins such as tyrosine and serine 
kinases or phosphatases with the cytoskeleton are 
prevalent. These signaling proteins are predicted 
to regulate the architecture of these dynamic 
structures.
Vesicle Transport and Podosome/
Invadopodia Formation
Both podosomes and invadopodia contain small 
GTP binding proteins and regulatory proteins that 
that control their function. Within this class of 
proteins, dynamin and endophilin stand out as 
proteins that could bridge interactions of GTP 
binding proteins with membranes and promote 
the formation of a secretory canaliculi or the 
docking of vesicle membranes. Lastly, a variety 
of proteases are apparent, and most of them have 
been detected in invadopodia. To this end it is 
noteworthy that in invadopodia, TIMP-2 is able 
to block protease activity whereas TIMP-1 was 
not, indicating that invadopodia are more depen-
dent upon membrane bound proteases than 
secreted proteases (Chen and Wang, 1999). Inter-
estingly, both podosomes and invadopodia forma-
tion may require exocytosis, as brefeldin A and 
Exo 1 will block the formation of invadopodia 
and podosomes (Ayala et al. 2006; Walker et al. 
2007). In this regard, it is also noteworthy that 
several proteins found associated with podosomes 
or invadopodia are normally associated with 
perinuclear vesicles in quiescent, normal cells, 
including cSrc, cortactin, Pyk2, dynamin 2, 
ADAM12, MT1-MMP and Tks5 (Kaplan et al. 
1992; Redmond et al. 1992; Howell and Cooper, 
1994; Fincham et al. 1996; Nicoziani et al. 2000; 
Hougaard et al. 2000; Kang et al. 2001). Thus, 
we would speculate that when cells make a deci-
sion to form a podosome or an invadopodia, 
outside-in signals could stimulate the movement 
of vesicles to the ventral membrane which in turn 
would deliver ‘cargo’ or protein components 
necessary for the formation of these structures. 
As podosomes and invadopodia will form rapidly, 
in less than 15 minutes after treatment with phor-
bol esters, and further, the formation of these 
structures do not require de novo protein synthesis 
(Linder and Aepfelbacher, 2003), and vesicle 
transport can be achieved rapidly and in less than 
15 minutes, it may be possible that vesicle transport 
could facilitate the trafﬁ  cking of podosome or 
invadopodia-associated proteins to the ventral 
membrane, which would allow construction of 
these structures and could offer a novel mecha-
nism for the formation of an invasive structure.
Invadopodia and Breast Cancer
Breast cancer cells will generate invadopodia in 
response to signals stimulated by growth factors, 
phorbol esters or interactions with the extracel-
lular matrix (Yamaguchi et al. 2005; Yamaguchi 
and Condeelis, 2007). MDA-MB-231 breast car-
cinoma cells are an excellent system for studying 
invasion and metastasis and they will form inva-
dopodia in response to stimuli. It is noteworthy 
that many proteins required for or associated with 
invadopodia formation are also associated with 
breast cancer progression, either through activa-
tion of signaling potential or changes in expression 
levels. In MDA-MB-231 cells, the expression 
levels and the signaling potential of the small GTP 
binding protein Arf6 was required for breast 
cancer invasion (Hashimoto et al. 2004; Onodera 
et al. 2005; Nam et al. 2007). Interestingly, Arf6 
will relay signals from phorbol esters that promote 
phospholipase D activation and phosphatidic acid 
production, the latter of which is a component of 
vesicle membranes (Xu et al. 2003). Arf6 will 
couple with RalA, which can regulate the transport 
of vesicles to the ventral membrane (Caumont 
et al. 1998). Thus, it may be possible that Arf6 
signaling is required for promoting phorbol ester 
or growth factor directed transport of vesicles to 
the ventral membrane that promote invadopodia 
formation. Another important signaling protein in 
breast cancer and invadopodia formation is cSrc, 25
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which exists on perinuclear vesicles and becomes 
activated upon trafficking to the membrane 
(Sandilands et al. 2004). cSrc is activated in breast 
cancer and will promote breast cancer formation 
in animal models. cSrc activation is a requirement 
for podosome and invadopodia formation (Linder, 
2007). Indeed, the initial description of podosomes 
was associated with expression of the constitutively 
activated v-Src in ﬁ  broblasts (Tarone et al. 1985; 
Marchisio et al. 1988; Gavazzi et al. 1989). cSrc will 
phosphorylate a number of proteins on tyrosine and 
many of those substrates are relevant to breast cancer 
progression and are also found associated with both 
podosomes and invadopodia. Interestingly, phospho-
tyrosine signals will coalesce in podosomes and 
invadopodia (Kanner et al. 1991; Bowden et al. 
2006). To this end, it is noteworthy that expression 
of the cSrc substrates cortactin and Tks5 are required 
for podosome formation (Seals et al. 2005; Webb 
et al. 2006). cSrc appears to play a role in podosome 
turnover and both the cSrc regulating protein CSK, 
as well as the tyrosine phosphatase PTP1B are 
required for podosome formation, likely by regulat-
ing dynamic changes in cSrc activity (Howell and 
Cooper, 1994; Cortesio et al. 2008). Each of these 
proteins are upregulated in breast cancer tissues and 
thus, could be well positioned to promote the forma-
tion of invasive structures and progression to an 
invasive phenotype. Thus, the protein components 
of podosomes and invadopodia may be very relevant 
to breast cancer.
Podosome and Invadopodia 
Proteins May React to the Tumor 
Microenvironment
Other podosome and invadopodia associated 
proteins may also play important roles in the 
interpretation of outside-in signals that promote 
invasive potential. In the Met-1 breast cancer 
model system, the adhesion protein CD44 plays 
a role in invadopodia formation by linking ankyrin 
to the contractile actomyosin system (Bourguignon 
et al. 1998). In this regard, it may be possible that 
the adhesion aspects of podosomes, which do 
appear to differentiate them from invadopodia, 
could be regulated by contractile forces, much 
like focal adhesion plaques require negative con-
tractile forces to promote adhesion (Dorﬂ  eutner 
et al. 2007). Studies in the MDA-MB-231 breast 
cancer cell line demonstrated that invadopodia 
will form in a stepwise fashion and promote 
invasive activity of breast carcinoma cells via 
expression of MT1-MMP (Kelly et al. 1998; 
Artym et al. 2006).
The ability of breast cancer cell lines to promote 
invasion and degradation of the extracellular 
matrix also correlated with an ability to phagocy-
tose digested extracellular matrix proteins (Coop-
man et al. 1998). This function may be regulated 
by endophilin-2, SHIP-2, CIN85 and/or synapto-
janin-2. SHIP-2 is an inositol 5-phosphatase found 
in podosomes, which removes the 5’ phosphate 
from phosphatidlyinositol-3,4,5-phosphate (Pes-
esse et al. 1998; Erneux et al. 1998). SHIP-2 is able 
to down regulate Fcγ-receptor mediated phagocy-
tosis (independent of SHIP-1) and does this via an 
ability to down regulate Rac activity (Ai et al. 
2006). Similarly, synaptojanin-2 is an inositol 5’-
phosphatase found in invadopodia that regulates 
endocytic vesicle trafﬁ  cking (Singer-Kruger et al. 
1998). Synaptojanin-2 will bind to activated Rac 
and negatively regulate endocytosis (Malecz et al. 
2000). Synaptojanin-2 is recruited to the membrane 
and stabilized by interactions with endophilin, 
which promotes clathrin-mediated endocytosis 
(Song and Zinsmaier, 2003). Interestingly, 
endophilin will also bridge interactions with dyna-
min 2 in podosomes (Ochoa et al. 2000) as well as 
with CIN85 (Petrelli et al. 2002). Here, a CIN85/
endophilin complex was shown to affect changes 
in membrane curvature, which is consistent with 
a role for dynamin 2. Thus, the SHIP2 and/or syn-
aptojanin-2/endophilin/dynamin-2/CIN85 proteins 
may play an important role in regulating the phago-
cytic activity associated with invasion by invado-
podia as well as changes in membrane curvature 
that may promote vesicle trafﬁ  cking or protease 
release. By this rationale, their appearance and 
association with invadopodia may be consistent 
with the function of these invasive structures. 
Further, it could be speculated that both invadopo-
dia and podosomes utilize these signaling proteins 
in a similar manner to promote invasive potential. 
If true, then each of these proteins might be inter-
esting drug targets that could be exploited to con-
trol breast cancer invasion.
Summary
We have contrasted the differences and similarities 
between podosomes and invadopodia by cataloging 
the proteins found in these invasive structures and 
comparing their known and predicted functions for 26
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normal cells (podosomes) and carcinoma cells 
(invadopodia) in an effort to address the hypothesis 
that these two invasive structures may be related. 
To date, their is no evidence to indicate that inva-
dopodia are derived from podosomes, or that each 
of these structures are derived from a common pre-
cursor structure. The major differences between the 
two are size, dependence on microtubular structures 
and subcellular localization upon the ventral mem-
brane, whereby invadopodia are found below the 
Golgi bodies, while podosomes can be found either 
centrally located or at the leading edge of a migrat-
ing cell (Gimona et al. 2008). However, we specu-
late that given the common cellular signals that 
regulate their construction, common protein com-
ponents and architecture, common size, shape and 
ventral membrane location, that these two structures 
are related. Further, a number of studies have shown 
the requirement for speciﬁ  c protein components in 
podosome and invadopodium formation and these 
same proteins are required for breast carcinoma cell 
invasion and are also expressed at high levels in 
breast cancer tissues. Probably the most interesting 
of these results were those done by Courtneidge and 
colleagues who have shown quite nicely the cor-
relation between Tks5 in expression in breast cancer 
cells and its role in podosome formation and inva-
sion (Seals et al. 2005). Future studies should focus 
on determining if theses structures are related and 
their role in breast cancer invasion, which will fos-
ter studies designed to create inhibitors that block 
invadopodia and podosome formation that may 
prevent breast carcinoma cells from invading.
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